

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.41266978 |
| 2 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.16843984 |
| 3 | synaptic vesicle maturation (GO:0016188) | 4.94648709 |
| 4 | vocalization behavior (GO:0071625) | 4.74304357 |
| 5 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.66937422 |
| 6 | locomotory exploration behavior (GO:0035641) | 4.66088606 |
| 7 | neuron cell-cell adhesion (GO:0007158) | 4.54635710 |
| 8 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.50358794 |
| 9 | glutamate secretion (GO:0014047) | 4.48340607 |
| 10 | protein localization to synapse (GO:0035418) | 4.45287284 |
| 11 | synaptic vesicle exocytosis (GO:0016079) | 4.40357965 |
| 12 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.37238897 |
| 13 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.35726020 |
| 14 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.24236383 |
| 15 | layer formation in cerebral cortex (GO:0021819) | 4.18821111 |
| 16 | axonal fasciculation (GO:0007413) | 4.01086201 |
| 17 | cell migration in hindbrain (GO:0021535) | 3.97231962 |
| 18 | neuronal action potential propagation (GO:0019227) | 3.96828533 |
| 19 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.91974498 |
| 20 | exploration behavior (GO:0035640) | 3.91118552 |
| 21 | dendritic spine morphogenesis (GO:0060997) | 3.90808709 |
| 22 | neuron recognition (GO:0008038) | 3.88280578 |
| 23 | regulation of synaptic vesicle transport (GO:1902803) | 3.86584945 |
| 24 | axon ensheathment in central nervous system (GO:0032291) | 3.79809675 |
| 25 | central nervous system myelination (GO:0022010) | 3.79809675 |
| 26 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.77053278 |
| 27 | neurotransmitter secretion (GO:0007269) | 3.74131807 |
| 28 | proline transport (GO:0015824) | 3.66527322 |
| 29 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.63120765 |
| 30 | synaptic transmission, glutamatergic (GO:0035249) | 3.62075643 |
| 31 | glutamate receptor signaling pathway (GO:0007215) | 3.57369639 |
| 32 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.56957477 |
| 33 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.52427155 |
| 34 | membrane depolarization during action potential (GO:0086010) | 3.49241544 |
| 35 | postsynaptic membrane organization (GO:0001941) | 3.47229948 |
| 36 | regulation of synapse structural plasticity (GO:0051823) | 3.45987709 |
| 37 | dendrite morphogenesis (GO:0048813) | 3.42300218 |
| 38 | innervation (GO:0060384) | 3.41988405 |
| 39 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.35109953 |
| 40 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.33267411 |
| 41 | neuron-neuron synaptic transmission (GO:0007270) | 3.31095569 |
| 42 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.29517856 |
| 43 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.28910119 |
| 44 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.28496095 |
| 45 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.27015276 |
| 46 | activation of protein kinase A activity (GO:0034199) | 3.23180665 |
| 47 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.22889082 |
| 48 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.21767552 |
| 49 | synaptic vesicle endocytosis (GO:0048488) | 3.18448819 |
| 50 | regulation of vesicle fusion (GO:0031338) | 3.14676745 |
| 51 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.13528064 |
| 52 | neuromuscular process controlling balance (GO:0050885) | 3.13522033 |
| 53 | transmission of nerve impulse (GO:0019226) | 3.13312004 |
| 54 | regulation of postsynaptic membrane potential (GO:0060078) | 3.12890672 |
| 55 | positive regulation of synapse maturation (GO:0090129) | 3.12035267 |
| 56 | long-term memory (GO:0007616) | 3.11832118 |
| 57 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.09585392 |
| 58 | negative regulation of microtubule polymerization (GO:0031115) | 3.08905331 |
| 59 | regulation of neurotransmitter secretion (GO:0046928) | 3.08064806 |
| 60 | neurotransmitter transport (GO:0006836) | 3.02122974 |
| 61 | membrane depolarization (GO:0051899) | 2.99578708 |
| 62 | cell communication by electrical coupling (GO:0010644) | 2.99184963 |
| 63 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.98429051 |
| 64 | gamma-aminobutyric acid transport (GO:0015812) | 2.98208748 |
| 65 | positive regulation of membrane potential (GO:0045838) | 2.97224032 |
| 66 | cerebellar granule cell differentiation (GO:0021707) | 2.97066584 |
| 67 | neuromuscular synaptic transmission (GO:0007274) | 2.93236296 |
| 68 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.92574196 |
| 69 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.92391340 |
| 70 | neuronal ion channel clustering (GO:0045161) | 2.92268988 |
| 71 | cellular potassium ion homeostasis (GO:0030007) | 2.92223750 |
| 72 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.92120886 |
| 73 | regulation of synaptic plasticity (GO:0048167) | 2.91657192 |
| 74 | synapse assembly (GO:0007416) | 2.91199378 |
| 75 | presynaptic membrane assembly (GO:0097105) | 2.90669383 |
| 76 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.86924657 |
| 77 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.86708437 |
| 78 | cell-cell junction maintenance (GO:0045217) | 2.85986413 |
| 79 | auditory behavior (GO:0031223) | 2.83615080 |
| 80 | dendritic spine organization (GO:0097061) | 2.83427951 |
| 81 | cerebellar Purkinje cell layer development (GO:0021680) | 2.82506013 |
| 82 | positive regulation of synapse assembly (GO:0051965) | 2.81527778 |
| 83 | vesicle transport along microtubule (GO:0047496) | 2.80587270 |
| 84 | establishment of mitochondrion localization (GO:0051654) | 2.80159844 |
| 85 | regulation of neurotransmitter transport (GO:0051588) | 2.79102269 |
| 86 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.78993380 |
| 87 | regulation of respiratory system process (GO:0044065) | 2.78099086 |
| 88 | neuromuscular process (GO:0050905) | 2.77880327 |
| 89 | mechanosensory behavior (GO:0007638) | 2.76099922 |
| 90 | regulation of synapse maturation (GO:0090128) | 2.75654145 |
| 91 | positive regulation of dendritic spine development (GO:0060999) | 2.75319380 |
| 92 | synapse organization (GO:0050808) | 2.75070418 |
| 93 | organelle transport along microtubule (GO:0072384) | 2.75001430 |
| 94 | chemosensory behavior (GO:0007635) | 2.74898089 |
| 95 | axon cargo transport (GO:0008088) | 2.73137194 |
| 96 | positive regulation of neurotransmitter transport (GO:0051590) | 2.73058682 |
| 97 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.72121281 |
| 98 | neuronal action potential (GO:0019228) | 2.71715639 |
| 99 | regulation of neurotransmitter levels (GO:0001505) | 2.71472747 |
| 100 | social behavior (GO:0035176) | 2.71412280 |
| 101 | intraspecies interaction between organisms (GO:0051703) | 2.71412280 |
| 102 | mating behavior (GO:0007617) | 2.71338676 |
| 103 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.71091746 |
| 104 | neuromuscular process controlling posture (GO:0050884) | 2.69006349 |
| 105 | nucleobase catabolic process (GO:0046113) | 2.68563761 |
| 106 | presynaptic membrane organization (GO:0097090) | 2.68377109 |
| 107 | axon extension (GO:0048675) | 2.68342489 |
| 108 | response to auditory stimulus (GO:0010996) | 2.67778751 |
| 109 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.67512508 |
| 110 | learning (GO:0007612) | 2.67401688 |
| 111 | establishment of nucleus localization (GO:0040023) | 2.66554563 |
| 112 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.66142800 |
| 113 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.66093906 |
| 114 | mitochondrion transport along microtubule (GO:0047497) | 2.62342287 |
| 115 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.62342287 |
| 116 | sodium ion export (GO:0071436) | 2.61183518 |
| 117 | cell junction maintenance (GO:0034331) | 2.49558067 |
| 118 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.43982948 |
| 119 | negative regulation of catenin import into nucleus (GO:0035414) | 2.42414351 |
| 120 | positive regulation of dendrite development (GO:1900006) | 2.42264712 |
| 121 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.39952498 |
| 122 | L-amino acid import (GO:0043092) | 2.39254061 |
| 123 | response to dietary excess (GO:0002021) | 2.37753077 |
| 124 | dopamine receptor signaling pathway (GO:0007212) | 2.36670934 |
| 125 | semaphorin-plexin signaling pathway (GO:0071526) | 2.36318896 |
| 126 | cellular sodium ion homeostasis (GO:0006883) | 2.33147420 |
| 127 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.29703038 |
| 128 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.29374610 |
| 129 | potassium ion homeostasis (GO:0055075) | 2.27414589 |
| 130 | amino acid import (GO:0043090) | 2.26836307 |
| 131 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.25150743 |
| 132 | potassium ion import (GO:0010107) | 2.21402395 |
| 133 | regulation of axonogenesis (GO:0050770) | 2.21058715 |
| 134 | negative regulation of axonogenesis (GO:0050771) | 2.20734345 |
| 135 | camera-type eye morphogenesis (GO:0048593) | 2.18988536 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.08130758 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.44529863 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.10767453 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.07291002 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.95238019 |
| 6 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.76094967 |
| 7 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.75930854 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.74591656 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.74591656 |
| 10 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.63751595 |
| 11 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.63010452 |
| 12 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.55367819 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.54240305 |
| 14 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.51893041 |
| 15 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.50428280 |
| 16 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.47447151 |
| 17 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.44765884 |
| 18 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.42918540 |
| 19 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 2.32980609 |
| 20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.28600930 |
| 21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.26927102 |
| 22 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.21704334 |
| 23 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.21579427 |
| 24 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.18052348 |
| 25 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.17938752 |
| 26 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.05339017 |
| 27 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.99730892 |
| 28 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.98771599 |
| 29 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.89216363 |
| 30 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.76005005 |
| 31 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.74669462 |
| 32 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.70624750 |
| 33 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.60881158 |
| 34 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.58389737 |
| 35 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.57294989 |
| 36 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.56962909 |
| 37 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.54774737 |
| 38 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.52976930 |
| 39 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.51879357 |
| 40 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.51615672 |
| 41 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.51455114 |
| 42 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.50338922 |
| 43 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.50065405 |
| 44 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.50064325 |
| 45 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.45537279 |
| 46 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.43439834 |
| 47 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.41999346 |
| 48 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.39942395 |
| 49 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.36962215 |
| 50 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.34532020 |
| 51 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.34281073 |
| 52 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.33085947 |
| 53 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.30953698 |
| 54 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.30351616 |
| 55 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.30337500 |
| 56 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.27929149 |
| 57 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.27669408 |
| 58 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.27426249 |
| 59 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.26288975 |
| 60 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.25399603 |
| 61 | P300_19829295_ChIP-Seq_ESCs_Human | 1.25217798 |
| 62 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.24393699 |
| 63 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.23732636 |
| 64 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.23181595 |
| 65 | STAT3_23295773_ChIP-Seq_U87_Human | 1.23069482 |
| 66 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.22630219 |
| 67 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.22200779 |
| 68 | AR_19668381_ChIP-Seq_PC3_Human | 1.21163711 |
| 69 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.20290032 |
| 70 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.20200632 |
| 71 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.19667014 |
| 72 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.18450385 |
| 73 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.17914945 |
| 74 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.16015482 |
| 75 | AR_25329375_ChIP-Seq_VCAP_Human | 1.15386029 |
| 76 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.13128853 |
| 77 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.13084145 |
| 78 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.12549690 |
| 79 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.12501868 |
| 80 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.12434901 |
| 81 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.10058882 |
| 82 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.09280977 |
| 83 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.09037962 |
| 84 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.06218403 |
| 85 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.05653203 |
| 86 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.04279304 |
| 87 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.03991434 |
| 88 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.03921388 |
| 89 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.02878007 |
| 90 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.02409056 |
| 91 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.01896413 |
| 92 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.01879995 |
| 93 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.01327650 |
| 94 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.99956222 |
| 95 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.99710227 |
| 96 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.99580935 |
| 97 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.99319068 |
| 98 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.98802379 |
| 99 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.98744417 |
| 100 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.98598023 |
| 101 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.98587640 |
| 102 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.98150034 |
| 103 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97684662 |
| 104 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.97180348 |
| 105 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.95876308 |
| 106 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.95284543 |
| 107 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.95154761 |
| 108 | * P68_20966046_ChIP-Seq_HELA_Human | 0.94435229 |
| 109 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.93795728 |
| 110 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.93347927 |
| 111 | FUS_26573619_Chip-Seq_HEK293_Human | 0.92003906 |
| 112 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.89347663 |
| 113 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.89004860 |
| 114 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.88901853 |
| 115 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88485232 |
| 116 | TP53_16413492_ChIP-PET_HCT116_Human | 0.87190228 |
| 117 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.86893302 |
| 118 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.86585919 |
| 119 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.86557145 |
| 120 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.86539295 |
| 121 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.86217866 |
| 122 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 0.86136104 |
| 123 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.86002055 |
| 124 | * SOX3_22085726_ChIP-Seq_NPCs_Mouse | 0.85920973 |
| 125 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.85822826 |
| 126 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.85414170 |
| 127 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.85343891 |
| 128 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.84100129 |
| 129 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.82184602 |
| 130 | * NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.81586914 |
| 131 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.80535027 |
| 132 | * KLF4_19829295_ChIP-Seq_ESCs_Human | 0.79244659 |
| 133 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.78527459 |
| 134 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.78086804 |
| 135 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.75178683 |
| 136 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.75098550 |
| 137 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.74786248 |
| 138 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.74619982 |
| 139 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.73668302 |
| 140 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.73320007 |
| 141 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.72898136 |
| 142 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.68777153 |
| 143 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.68139958 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.48214558 |
| 2 | MP0003880_abnormal_central_pattern | 4.08842576 |
| 3 | MP0004270_analgesia | 3.67920874 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.55116832 |
| 5 | MP0001968_abnormal_touch/_nociception | 3.37199265 |
| 6 | MP0002735_abnormal_chemical_nociception | 2.99440968 |
| 7 | MP0002063_abnormal_learning/memory/cond | 2.81399917 |
| 8 | MP0009745_abnormal_behavioral_response | 2.75772719 |
| 9 | MP0002734_abnormal_mechanical_nocicepti | 2.73880196 |
| 10 | MP0002822_catalepsy | 2.59861660 |
| 11 | MP0002736_abnormal_nociception_after | 2.56823163 |
| 12 | MP0005423_abnormal_somatic_nervous | 2.56602633 |
| 13 | MP0006276_abnormal_autonomic_nervous | 2.46364687 |
| 14 | MP0002064_seizures | 2.45995622 |
| 15 | MP0004858_abnormal_nervous_system | 2.40066720 |
| 16 | MP0002572_abnormal_emotion/affect_behav | 2.37933994 |
| 17 | MP0002733_abnormal_thermal_nociception | 2.36909864 |
| 18 | MP0003283_abnormal_digestive_organ | 2.25905357 |
| 19 | MP0009046_muscle_twitch | 2.24924034 |
| 20 | MP0002272_abnormal_nervous_system | 2.16142188 |
| 21 | MP0001970_abnormal_pain_threshold | 2.09828176 |
| 22 | MP0002184_abnormal_innervation | 2.07309495 |
| 23 | MP0003122_maternal_imprinting | 2.03206910 |
| 24 | MP0000778_abnormal_nervous_system | 1.99783295 |
| 25 | MP0001486_abnormal_startle_reflex | 1.92040944 |
| 26 | MP0009780_abnormal_chondrocyte_physiolo | 1.87345628 |
| 27 | MP0000566_synostosis | 1.85435744 |
| 28 | MP0005409_darkened_coat_color | 1.80713235 |
| 29 | MP0002067_abnormal_sensory_capabilities | 1.80471690 |
| 30 | MP0004811_abnormal_neuron_physiology | 1.77312803 |
| 31 | MP0001440_abnormal_grooming_behavior | 1.75764661 |
| 32 | MP0002909_abnormal_adrenal_gland | 1.69651608 |
| 33 | MP0000955_abnormal_spinal_cord | 1.69230849 |
| 34 | MP0001501_abnormal_sleep_pattern | 1.67943029 |
| 35 | MP0002249_abnormal_larynx_morphology | 1.64070567 |
| 36 | MP0002557_abnormal_social/conspecific_i | 1.59417877 |
| 37 | MP0010386_abnormal_urinary_bladder | 1.57175516 |
| 38 | MP0003787_abnormal_imprinting | 1.48729626 |
| 39 | MP0003690_abnormal_glial_cell | 1.44450211 |
| 40 | MP0004924_abnormal_behavior | 1.44422779 |
| 41 | MP0005386_behavior/neurological_phenoty | 1.44422779 |
| 42 | MP0005167_abnormal_blood-brain_barrier | 1.42509155 |
| 43 | * MP0002882_abnormal_neuron_morphology | 1.40395843 |
| 44 | MP0003329_amyloid_beta_deposits | 1.37367886 |
| 45 | MP0005646_abnormal_pituitary_gland | 1.35800367 |
| 46 | MP0005645_abnormal_hypothalamus_physiol | 1.35154173 |
| 47 | MP0000569_abnormal_digit_pigmentation | 1.32782876 |
| 48 | MP0008569_lethality_at_weaning | 1.32726319 |
| 49 | MP0003879_abnormal_hair_cell | 1.30144797 |
| 50 | MP0001188_hyperpigmentation | 1.28642231 |
| 51 | MP0000751_myopathy | 1.27589813 |
| 52 | MP0002066_abnormal_motor_capabilities/c | 1.25291661 |
| 53 | MP0004145_abnormal_muscle_electrophysio | 1.24253014 |
| 54 | MP0001984_abnormal_olfaction | 1.20786768 |
| 55 | MP0005670_abnormal_white_adipose | 1.18323799 |
| 56 | MP0010368_abnormal_lymphatic_system | 1.13886498 |
| 57 | MP0001299_abnormal_eye_distance/ | 1.12718413 |
| 58 | MP0005623_abnormal_meninges_morphology | 1.10467931 |
| 59 | MP0002152_abnormal_brain_morphology | 1.10202369 |
| 60 | MP0002234_abnormal_pharynx_morphology | 1.10006502 |
| 61 | MP0003938_abnormal_ear_development | 1.09458570 |
| 62 | MP0009379_abnormal_foot_pigmentation | 1.08276438 |
| 63 | MP0003136_yellow_coat_color | 1.08109169 |
| 64 | MP0000631_abnormal_neuroendocrine_gland | 1.07944072 |
| 65 | MP0001905_abnormal_dopamine_level | 1.06825475 |
| 66 | MP0002139_abnormal_hepatobiliary_system | 1.05982253 |
| 67 | MP0002653_abnormal_ependyma_morphology | 1.05847220 |
| 68 | MP0001502_abnormal_circadian_rhythm | 1.05297370 |
| 69 | MP0000534_abnormal_ureter_morphology | 1.02484540 |
| 70 | MP0002876_abnormal_thyroid_physiology | 1.00307318 |
| 71 | MP0005503_abnormal_tendon_morphology | 0.98356350 |
| 72 | MP0005365_abnormal_bile_salt | 0.96748221 |
| 73 | MP0003633_abnormal_nervous_system | 0.95796518 |
| 74 | MP0004885_abnormal_endolymph | 0.95653012 |
| 75 | MP0001529_abnormal_vocalization | 0.92329343 |
| 76 | MP0003123_paternal_imprinting | 0.90043767 |
| 77 | MP0003121_genomic_imprinting | 0.88384345 |
| 78 | MP0010329_abnormal_lipoprotein_level | 0.87402038 |
| 79 | MP0000013_abnormal_adipose_tissue | 0.86764847 |
| 80 | MP0000920_abnormal_myelination | 0.86019757 |
| 81 | MP0004142_abnormal_muscle_tone | 0.84614603 |
| 82 | MP0003631_nervous_system_phenotype | 0.84073297 |
| 83 | * MP0002751_abnormal_autonomic_nervous | 0.83353419 |
| 84 | * MP0002752_abnormal_somatic_nervous | 0.83222768 |
| 85 | MP0004130_abnormal_muscle_cell | 0.82887940 |
| 86 | MP0001348_abnormal_lacrimal_gland | 0.82715083 |
| 87 | MP0010030_abnormal_orbit_morphology | 0.82109687 |
| 88 | MP0003172_abnormal_lysosome_physiology | 0.81451882 |
| 89 | MP0003861_abnormal_nervous_system | 0.80884466 |
| 90 | MP0002837_dystrophic_cardiac_calcinosis | 0.80750636 |
| 91 | MP0003385_abnormal_body_wall | 0.80649728 |
| 92 | MP0005551_abnormal_eye_electrophysiolog | 0.78299822 |
| 93 | MP0000639_abnormal_adrenal_gland | 0.77544313 |
| 94 | MP0001177_atelectasis | 0.77543188 |
| 95 | MP0005187_abnormal_penis_morphology | 0.76951097 |
| 96 | MP0002069_abnormal_eating/drinking_beha | 0.75984334 |
| 97 | MP0004742_abnormal_vestibular_system | 0.75113878 |
| 98 | MP0002638_abnormal_pupillary_reflex | 0.74613270 |
| 99 | MP0005499_abnormal_olfactory_system | 0.73568988 |
| 100 | MP0005394_taste/olfaction_phenotype | 0.73568988 |
| 101 | MP0002229_neurodegeneration | 0.72963454 |
| 102 | MP0003195_calcinosis | 0.72311026 |
| 103 | MP0004085_abnormal_heartbeat | 0.71975299 |
| 104 | MP0003634_abnormal_glial_cell | 0.71426262 |
| 105 | MP0000604_amyloidosis | 0.71127011 |
| 106 | MP0001666_abnormal_nutrient_absorption | 0.71106371 |
| 107 | MP0006072_abnormal_retinal_apoptosis | 0.70792410 |
| 108 | MP0008961_abnormal_basal_metabolism | 0.70604316 |
| 109 | MP0001963_abnormal_hearing_physiology | 0.70376179 |
| 110 | MP0000678_abnormal_parathyroid_gland | 0.69986872 |
| 111 | MP0003942_abnormal_urinary_system | 0.66933576 |
| 112 | MP0003632_abnormal_nervous_system | 0.64304830 |
| 113 | MP0001943_abnormal_respiration | 0.59825801 |
| 114 | MP0002089_abnormal_postnatal_growth/wei | 0.58870133 |
| 115 | MP0001986_abnormal_taste_sensitivity | 0.57403464 |
| 116 | MP0006292_abnormal_olfactory_placode | 0.56023239 |
| 117 | MP0000538_abnormal_urinary_bladder | 0.55621559 |
| 118 | MP0004233_abnormal_muscle_weight | 0.53607713 |
| 119 | MP0000026_abnormal_inner_ear | 0.53458723 |
| 120 | MP0003119_abnormal_digestive_system | 0.53015350 |
| 121 | MP0004133_heterotaxia | 0.52962833 |
| 122 | MP0002081_perinatal_lethality | 0.52677750 |
| 123 | MP0001485_abnormal_pinna_reflex | 0.51347532 |
| 124 | MP0002896_abnormal_bone_mineralization | 0.51019689 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 5.62546302 |
| 2 | Focal motor seizures (HP:0011153) | 5.41479580 |
| 3 | Focal seizures (HP:0007359) | 4.87935535 |
| 4 | Visual hallucinations (HP:0002367) | 4.01187561 |
| 5 | Atonic seizures (HP:0010819) | 3.67536531 |
| 6 | Febrile seizures (HP:0002373) | 3.64700458 |
| 7 | Epileptic encephalopathy (HP:0200134) | 3.56138605 |
| 8 | Neurofibrillary tangles (HP:0002185) | 3.49942264 |
| 9 | Action tremor (HP:0002345) | 3.45329603 |
| 10 | Ankle clonus (HP:0011448) | 3.33184653 |
| 11 | Progressive cerebellar ataxia (HP:0002073) | 3.31846445 |
| 12 | Supranuclear gaze palsy (HP:0000605) | 3.19778487 |
| 13 | Absence seizures (HP:0002121) | 3.10121546 |
| 14 | Deep venous thrombosis (HP:0002625) | 3.07533202 |
| 15 | Generalized tonic-clonic seizures (HP:0002069) | 3.04915938 |
| 16 | Amblyopia (HP:0000646) | 2.95573202 |
| 17 | Dialeptic seizures (HP:0011146) | 2.90298800 |
| 18 | Lymphangioma (HP:0100764) | 2.89400846 |
| 19 | Bronchomalacia (HP:0002780) | 2.83435028 |
| 20 | Complement deficiency (HP:0004431) | 2.76830411 |
| 21 | Broad-based gait (HP:0002136) | 2.72924480 |
| 22 | Abnormality of the aortic arch (HP:0012303) | 2.72459178 |
| 23 | Vitreoretinal degeneration (HP:0000655) | 2.65723363 |
| 24 | Depression (HP:0000716) | 2.60479369 |
| 25 | Hypoventilation (HP:0002791) | 2.60260248 |
| 26 | Turricephaly (HP:0000262) | 2.58320965 |
| 27 | Sleep apnea (HP:0010535) | 2.56301322 |
| 28 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.53712306 |
| 29 | Truncal ataxia (HP:0002078) | 2.53038748 |
| 30 | Insomnia (HP:0100785) | 2.52787445 |
| 31 | Termporal pattern (HP:0011008) | 2.52447869 |
| 32 | Insidious onset (HP:0003587) | 2.52447869 |
| 33 | Ulnar claw (HP:0001178) | 2.39129123 |
| 34 | Limb dystonia (HP:0002451) | 2.37922170 |
| 35 | Papilledema (HP:0001085) | 2.37065554 |
| 36 | Excessive salivation (HP:0003781) | 2.36750038 |
| 37 | Drooling (HP:0002307) | 2.36750038 |
| 38 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.35477190 |
| 39 | Exotropia (HP:0000577) | 2.34732240 |
| 40 | Poor eye contact (HP:0000817) | 2.34192012 |
| 41 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.33892220 |
| 42 | Agitation (HP:0000713) | 2.33514308 |
| 43 | Abnormality of the lower motor neuron (HP:0002366) | 2.28126914 |
| 44 | Shallow orbits (HP:0000586) | 2.26243132 |
| 45 | Urinary urgency (HP:0000012) | 2.25326420 |
| 46 | Gaze-evoked nystagmus (HP:0000640) | 2.24515794 |
| 47 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.24357865 |
| 48 | Polyphagia (HP:0002591) | 2.23175130 |
| 49 | Torticollis (HP:0000473) | 2.20573900 |
| 50 | Pointed chin (HP:0000307) | 2.20196982 |
| 51 | Diplopia (HP:0000651) | 2.19288322 |
| 52 | Abnormality of binocular vision (HP:0011514) | 2.19288322 |
| 53 | Epileptiform EEG discharges (HP:0011182) | 2.18747030 |
| 54 | Mutism (HP:0002300) | 2.18109632 |
| 55 | Hemiparesis (HP:0001269) | 2.16179340 |
| 56 | Abnormality of the ischium (HP:0003174) | 2.15859490 |
| 57 | Abnormal eating behavior (HP:0100738) | 2.15647364 |
| 58 | Hepatoblastoma (HP:0002884) | 2.15355916 |
| 59 | Anxiety (HP:0000739) | 2.13840625 |
| 60 | EEG with generalized epileptiform discharges (HP:0011198) | 2.11991876 |
| 61 | Pheochromocytoma (HP:0002666) | 2.11965054 |
| 62 | Spastic gait (HP:0002064) | 2.11369958 |
| 63 | Hyperventilation (HP:0002883) | 2.10739108 |
| 64 | Impaired social interactions (HP:0000735) | 2.08951085 |
| 65 | Abnormal social behavior (HP:0012433) | 2.08951085 |
| 66 | Alacrima (HP:0000522) | 2.08515681 |
| 67 | Neoplasm of the heart (HP:0100544) | 2.08128841 |
| 68 | Failure to thrive in infancy (HP:0001531) | 2.07285444 |
| 69 | Broad metatarsal (HP:0001783) | 2.07157723 |
| 70 | Cerebral aneurysm (HP:0004944) | 2.07050634 |
| 71 | Hypsarrhythmia (HP:0002521) | 2.06193771 |
| 72 | Dysdiadochokinesis (HP:0002075) | 2.05715868 |
| 73 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.05482406 |
| 74 | Lower limb amyotrophy (HP:0007210) | 2.04844297 |
| 75 | Absent speech (HP:0001344) | 2.03636422 |
| 76 | Hyperlipoproteinemia (HP:0010980) | 2.03446748 |
| 77 | Narrow nasal bridge (HP:0000446) | 2.01862570 |
| 78 | Abnormality of pain sensation (HP:0010832) | 2.01821671 |
| 79 | Impaired pain sensation (HP:0007328) | 2.01821671 |
| 80 | Dysmetria (HP:0001310) | 2.00094797 |
| 81 | Peripheral hypomyelination (HP:0007182) | 1.99777462 |
| 82 | Impaired smooth pursuit (HP:0007772) | 1.98172490 |
| 83 | Hypoplastic ischia (HP:0003175) | 1.98083720 |
| 84 | Genetic anticipation (HP:0003743) | 1.94371230 |
| 85 | Visceral angiomatosis (HP:0100761) | 1.94351740 |
| 86 | Hypoplasia of the brainstem (HP:0002365) | 1.92976150 |
| 87 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.92976150 |
| 88 | Congenital malformation of the right heart (HP:0011723) | 1.90774719 |
| 89 | Double outlet right ventricle (HP:0001719) | 1.90774719 |
| 90 | Hypercortisolism (HP:0001578) | 1.90604963 |
| 91 | Postural instability (HP:0002172) | 1.90389100 |
| 92 | Lower limb muscle weakness (HP:0007340) | 1.89911821 |
| 93 | Megalencephaly (HP:0001355) | 1.87357095 |
| 94 | Bowel diverticulosis (HP:0005222) | 1.86824804 |
| 95 | Obstructive sleep apnea (HP:0002870) | 1.86202728 |
| 96 | Renal duplication (HP:0000075) | 1.84600372 |
| 97 | Stereotypic behavior (HP:0000733) | 1.84217410 |
| 98 | Anomalous pulmonary venous return (HP:0010772) | 1.84177635 |
| 99 | Abnormality of the corticospinal tract (HP:0002492) | 1.83487884 |
| 100 | Abnormality of complement system (HP:0005339) | 1.82799445 |
| 101 | Cerebral inclusion bodies (HP:0100314) | 1.82468458 |
| 102 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.81368695 |
| 103 | Focal dystonia (HP:0004373) | 1.81172614 |
| 104 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.81009439 |
| 105 | Aplasia of the phalanges of the hand (HP:0009802) | 1.81009439 |
| 106 | Aplasia involving bones of the extremities (HP:0009825) | 1.81009439 |
| 107 | Hammertoe (HP:0001765) | 1.79459969 |
| 108 | Hyperacusis (HP:0010780) | 1.79297152 |
| 109 | Truncus arteriosus (HP:0001660) | 1.79184511 |
| 110 | Elfin facies (HP:0004428) | 1.78986761 |
| 111 | Status epilepticus (HP:0002133) | 1.78379152 |
| 112 | Hypothermia (HP:0002045) | 1.78311190 |
| 113 | Akinesia (HP:0002304) | 1.78274562 |
| 114 | Intention tremor (HP:0002080) | 1.76699342 |
| 115 | Fetal akinesia sequence (HP:0001989) | 1.76621361 |
| 116 | Macroorchidism (HP:0000053) | 1.75906677 |
| 117 | Hyperthyroidism (HP:0000836) | 1.75560920 |
| 118 | Buphthalmos (HP:0000557) | 1.75309237 |
| 119 | Protruding tongue (HP:0010808) | 1.75150136 |
| 120 | Nuclear cataract (HP:0100018) | 1.74944867 |
| 121 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.73169013 |
| 122 | Cutaneous finger syndactyly (HP:0010554) | 1.73020484 |
| 123 | Neuroendocrine neoplasm (HP:0100634) | 1.72833809 |
| 124 | Bradykinesia (HP:0002067) | 1.71279887 |
| 125 | Delayed CNS myelination (HP:0002188) | 1.70825965 |
| 126 | Bradycardia (HP:0001662) | 1.70678779 |
| 127 | Flat cornea (HP:0007720) | 1.69995833 |
| 128 | Lower limb asymmetry (HP:0100559) | 1.69677596 |
| 129 | Bladder diverticulum (HP:0000015) | 1.68947693 |
| 130 | Craniofacial dystonia (HP:0012179) | 1.68406629 |
| 131 | Hemangiomatosis (HP:0007461) | 1.68396769 |
| 132 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.67983163 |
| 133 | Upper limb amyotrophy (HP:0009129) | 1.67981960 |
| 134 | Distal upper limb amyotrophy (HP:0007149) | 1.67981960 |
| 135 | Prolonged partial thromboplastin time (HP:0003645) | 1.67223398 |
| 136 | Specific learning disability (HP:0001328) | 1.66166133 |
| 137 | Aqueductal stenosis (HP:0002410) | 1.65877643 |
| 138 | Joint hemorrhage (HP:0005261) | 1.65344896 |
| 139 | Thickened helices (HP:0000391) | 1.65267508 |
| 140 | Renovascular hypertension (HP:0100817) | 1.64782912 |
| 141 | Xanthomatosis (HP:0000991) | 1.63123926 |
| 142 | Partial duplication of thumb phalanx (HP:0009944) | 1.62685305 |
| 143 | Hemiplegia (HP:0002301) | 1.62103731 |
| 144 | Prolonged QT interval (HP:0001657) | 1.62037292 |
| 145 | Cutaneous syndactyly (HP:0012725) | 1.61818340 |
| 146 | Systemic lupus erythematosus (HP:0002725) | 1.60748075 |
| 147 | Abnormality of the diencephalon (HP:0010662) | 1.59278288 |
| 148 | Annular pancreas (HP:0001734) | 1.59232314 |
| 149 | Rib fusion (HP:0000902) | 1.58954965 |
| 150 | Glomerulonephritis (HP:0000099) | 1.58938656 |
| 151 | Severe Myopia (HP:0011003) | 1.58869254 |
| 152 | Abnormality of the pulmonary veins (HP:0011718) | 1.56349446 |
| 153 | Tracheomalacia (HP:0002779) | 1.56114888 |
| 154 | Mixed hearing impairment (HP:0000410) | 1.55128061 |
| 155 | Hand muscle atrophy (HP:0009130) | 1.54622511 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * NTRK3 | 4.52443162 |
| 2 | MAP3K9 | 4.02917539 |
| 3 | EPHA4 | 3.63471818 |
| 4 | MARK1 | 3.40210948 |
| 5 | TNIK | 3.19275598 |
| 6 | MAP3K4 | 2.84354900 |
| 7 | MINK1 | 2.69386807 |
| 8 | RIPK1 | 2.52028351 |
| 9 | NTRK1 | 2.48986463 |
| 10 | MAP2K7 | 2.38247692 |
| 11 | PRKD3 | 2.25383609 |
| 12 | DAPK2 | 2.17257939 |
| 13 | PAK6 | 2.16232171 |
| 14 | KSR2 | 2.00915607 |
| 15 | MAPK13 | 1.96550302 |
| 16 | FGFR2 | 1.90924238 |
| 17 | CASK | 1.86452035 |
| 18 | LATS2 | 1.74648686 |
| 19 | MAP2K4 | 1.70056122 |
| 20 | TRIB3 | 1.67815622 |
| 21 | NTRK2 | 1.66545389 |
| 22 | MAP3K12 | 1.62536656 |
| 23 | PRPF4B | 1.60354343 |
| 24 | KSR1 | 1.52201163 |
| 25 | SIK1 | 1.46778114 |
| 26 | MAPK15 | 1.46663273 |
| 27 | CAMKK1 | 1.44410498 |
| 28 | CDK5 | 1.44024149 |
| 29 | UHMK1 | 1.43898544 |
| 30 | MAP3K2 | 1.43200572 |
| 31 | FGFR4 | 1.41262890 |
| 32 | PNCK | 1.38928452 |
| 33 | GRK5 | 1.38421135 |
| 34 | TIE1 | 1.32422380 |
| 35 | PLK2 | 1.27770201 |
| 36 | PHKG1 | 1.20547457 |
| 37 | PHKG2 | 1.20547457 |
| 38 | STK38 | 1.19205462 |
| 39 | DAPK1 | 1.17993876 |
| 40 | SIK2 | 1.15955093 |
| 41 | RET | 1.13741634 |
| 42 | DDR2 | 1.13133839 |
| 43 | PRKCG | 1.10572077 |
| 44 | PAK3 | 1.08574970 |
| 45 | TYRO3 | 1.04038659 |
| 46 | PDGFRA | 1.03105103 |
| 47 | PINK1 | 1.02786112 |
| 48 | PKN1 | 0.98889839 |
| 49 | SCYL2 | 0.98856726 |
| 50 | DYRK1B | 0.95115877 |
| 51 | MAP3K7 | 0.94258581 |
| 52 | CDC42BPA | 0.92033748 |
| 53 | FER | 0.90902315 |
| 54 | CDK14 | 0.89518982 |
| 55 | PKN2 | 0.88276870 |
| 56 | CAMK2A | 0.87819891 |
| 57 | CDK18 | 0.86528736 |
| 58 | RIPK4 | 0.86200591 |
| 59 | CAMKK2 | 0.85262817 |
| 60 | LMTK2 | 0.84856591 |
| 61 | CDK15 | 0.84797708 |
| 62 | CSNK1G2 | 0.81802993 |
| 63 | PRKCH | 0.81437549 |
| 64 | LIMK1 | 0.80160251 |
| 65 | MAP3K6 | 0.79705558 |
| 66 | SGK223 | 0.75718702 |
| 67 | SGK494 | 0.75718702 |
| 68 | MARK2 | 0.74771952 |
| 69 | TAOK1 | 0.73703449 |
| 70 | CAMK1D | 0.72377485 |
| 71 | CDK11A | 0.72369913 |
| 72 | RPS6KA2 | 0.71670841 |
| 73 | PRKAA1 | 0.70911840 |
| 74 | MAP2K6 | 0.70885694 |
| 75 | MAP3K1 | 0.70401979 |
| 76 | EPHA3 | 0.67712377 |
| 77 | CAMK1 | 0.64336682 |
| 78 | WNK1 | 0.64054627 |
| 79 | CAMK1G | 0.63474131 |
| 80 | MAP3K11 | 0.63343332 |
| 81 | PRKCE | 0.63140650 |
| 82 | ARAF | 0.63061571 |
| 83 | STK11 | 0.62764492 |
| 84 | EPHB2 | 0.62470910 |
| 85 | CAMK2B | 0.61851683 |
| 86 | MAPK12 | 0.61443641 |
| 87 | ALK | 0.60480227 |
| 88 | MAP2K1 | 0.60446286 |
| 89 | EEF2K | 0.60329334 |
| 90 | PTK2B | 0.59098792 |
| 91 | SGK1 | 0.57798310 |
| 92 | DYRK1A | 0.56818457 |
| 93 | CAMK2G | 0.55706613 |
| 94 | SGK2 | 0.55696977 |
| 95 | MTOR | 0.55401584 |
| 96 | FES | 0.54270661 |
| 97 | FGFR3 | 0.54120031 |
| 98 | WNK3 | 0.53779509 |
| 99 | DYRK2 | 0.51236611 |
| 100 | DMPK | 0.49555533 |
| 101 | PRKCZ | 0.49419720 |
| 102 | PRKD1 | 0.48578716 |
| 103 | PDGFRB | 0.47922791 |
| 104 | ERBB3 | 0.46881049 |
| 105 | ADRBK1 | 0.46243597 |
| 106 | PTK2 | 0.44833863 |
| 107 | RPS6KA3 | 0.43493815 |
| 108 | ROCK2 | 0.41964017 |
| 109 | SGK3 | 0.41516131 |
| 110 | SRC | 0.41503239 |
| 111 | ICK | 0.41432727 |
| 112 | BMX | 0.40808422 |
| 113 | MAPK4 | 0.40545303 |
| 114 | INSRR | 0.40413840 |
| 115 | MAPK10 | 0.39331196 |
| 116 | CAMK4 | 0.38811117 |
| 117 | CAMK2D | 0.38703060 |
| 118 | CSNK1E | 0.38357715 |
| 119 | FYN | 0.36933090 |
| 120 | PRKD2 | 0.35759865 |
| 121 | ROCK1 | 0.35496488 |
| 122 | HIPK2 | 0.35406913 |
| 123 | DAPK3 | 0.34958854 |
| 124 | PRKCB | 0.34334427 |
| 125 | TNK2 | 0.31752210 |
| 126 | MAPK8 | 0.30819089 |
| 127 | WNK4 | 0.30486302 |
| 128 | CSNK1G3 | 0.30061848 |
| 129 | ERBB2 | 0.29798267 |
| 130 | CSNK1A1L | 0.29723109 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.25835936 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.96988011 |
| 3 | Circadian entrainment_Homo sapiens_hsa04713 | 2.48589242 |
| 4 | Long-term potentiation_Homo sapiens_hsa04720 | 2.45201768 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.36173671 |
| 6 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.36146445 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.34662540 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.31461637 |
| 9 | Olfactory transduction_Homo sapiens_hsa04740 | 2.30387720 |
| 10 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.22394890 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.19483973 |
| 12 | Morphine addiction_Homo sapiens_hsa05032 | 2.18014684 |
| 13 | Insulin secretion_Homo sapiens_hsa04911 | 2.15550028 |
| 14 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.98824801 |
| 15 | Taste transduction_Homo sapiens_hsa04742 | 1.90284070 |
| 16 | Cocaine addiction_Homo sapiens_hsa05030 | 1.90109057 |
| 17 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.84473906 |
| 18 | Salivary secretion_Homo sapiens_hsa04970 | 1.73624369 |
| 19 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.72143949 |
| 20 | Bile secretion_Homo sapiens_hsa04976 | 1.67088887 |
| 21 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.65841580 |
| 22 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.65307456 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.60027424 |
| 24 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.59242519 |
| 25 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.58084545 |
| 26 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.57984472 |
| 27 | Long-term depression_Homo sapiens_hsa04730 | 1.56324555 |
| 28 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.55532321 |
| 29 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.53660693 |
| 30 | Axon guidance_Homo sapiens_hsa04360 | 1.48125131 |
| 31 | Gap junction_Homo sapiens_hsa04540 | 1.46048992 |
| 32 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.45916832 |
| 33 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.44201127 |
| 34 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.42223091 |
| 35 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.36922879 |
| 36 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.33140532 |
| 37 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.32475266 |
| 38 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.28180335 |
| 39 | Histidine metabolism_Homo sapiens_hsa00340 | 1.28020601 |
| 40 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.27441837 |
| 41 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.27107896 |
| 42 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.24440498 |
| 43 | Melanogenesis_Homo sapiens_hsa04916 | 1.24007010 |
| 44 | * Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.21699053 |
| 45 | * Glioma_Homo sapiens_hsa05214 | 1.17103095 |
| 46 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.15199557 |
| 47 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.13207733 |
| 48 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.12969788 |
| 49 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.07059538 |
| 50 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.05265958 |
| 51 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.03515140 |
| 52 | * ErbB signaling pathway_Homo sapiens_hsa04012 | 1.02305782 |
| 53 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.01370344 |
| 54 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.00841083 |
| 55 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.00267007 |
| 56 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.97812288 |
| 57 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.96727560 |
| 58 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.96441026 |
| 59 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.96425904 |
| 60 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.93892912 |
| 61 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.93536358 |
| 62 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.91103570 |
| 63 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.89493095 |
| 64 | Endometrial cancer_Homo sapiens_hsa05213 | 0.86447367 |
| 65 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.86293299 |
| 66 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.85429378 |
| 67 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.84027831 |
| 68 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.83918103 |
| 69 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.83609765 |
| 70 | Retinol metabolism_Homo sapiens_hsa00830 | 0.82552301 |
| 71 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.82186035 |
| 72 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.81536164 |
| 73 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.80404094 |
| 74 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.80337771 |
| 75 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.78792765 |
| 76 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.78639687 |
| 77 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.77827601 |
| 78 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.76634379 |
| 79 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.76633494 |
| 80 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.75224520 |
| 81 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.74177805 |
| 82 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.73812628 |
| 83 | ABC transporters_Homo sapiens_hsa02010 | 0.73326047 |
| 84 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.72965473 |
| 85 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.71040239 |
| 86 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.70160409 |
| 87 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.69991111 |
| 88 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.68902122 |
| 89 | Phototransduction_Homo sapiens_hsa04744 | 0.68822960 |
| 90 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.68232638 |
| 91 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.66545239 |
| 92 | * Alcoholism_Homo sapiens_hsa05034 | 0.66057327 |
| 93 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.65219995 |
| 94 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.65028417 |
| 95 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.64701629 |
| 96 | * Ras signaling pathway_Homo sapiens_hsa04014 | 0.64618287 |
| 97 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.62814476 |
| 98 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.62291268 |
| 99 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.62001206 |
| 100 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.60223978 |
| 101 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.60167807 |
| 102 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.59889469 |
| 103 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.59500262 |
| 104 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.59428489 |
| 105 | Lysine degradation_Homo sapiens_hsa00310 | 0.59176184 |
| 106 | Prion diseases_Homo sapiens_hsa05020 | 0.58842041 |
| 107 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.57478105 |
| 108 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.57111309 |
| 109 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.56124352 |
| 110 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.56009259 |
| 111 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.55795999 |
| 112 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.55793572 |
| 113 | * VEGF signaling pathway_Homo sapiens_hsa04370 | 0.55565840 |
| 114 | Colorectal cancer_Homo sapiens_hsa05210 | 0.55033556 |
| 115 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.54917712 |
| 116 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 0.53883466 |
| 117 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.53812019 |
| 118 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.53419335 |
| 119 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.52076399 |
| 120 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.51700284 |
| 121 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.51301550 |
| 122 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.51273268 |
| 123 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.50920462 |
| 124 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50909877 |
| 125 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.49348989 |
| 126 | Endocytosis_Homo sapiens_hsa04144 | 0.49099004 |
| 127 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.48952477 |
| 128 | Thyroid cancer_Homo sapiens_hsa05216 | 0.48881872 |
| 129 | Circadian rhythm_Homo sapiens_hsa04710 | 0.47810825 |
| 130 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.47277861 |
| 131 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.46623514 |
| 132 | Melanoma_Homo sapiens_hsa05218 | 0.45412397 |
| 133 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.41362407 |
| 134 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.40161271 |
| 135 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.40140150 |
| 136 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.36946754 |
| 137 | Tight junction_Homo sapiens_hsa04530 | 0.35441852 |
| 138 | * Focal adhesion_Homo sapiens_hsa04510 | 0.35065514 |
| 139 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.33765134 |

